Why T Cells Struggle Against Solid Tumors in Immunotherapy
Cell-based immunotherapies like CAR-T, CAR-NK, and TCR-T therapies have transformed blood cancer treatment, yet they encounter significant challenges when confronting solid tumors due to metabolic roadblocks, antigen heterogeneity, and immunosuppressive ... Read More